We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$50.8B
AUM Growth
-$294M
Cap. Flow
-$328M
Cap. Flow %
-0.65%
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$255M
2
TXT icon
Textron
TXT
+$206M
3
AZN icon
AstraZeneca
AZN
+$164M
4
XOM icon
ExxonMobil
XOM
+$124M
5
MRNA icon
Moderna
MRNA
+$121M

Sector Composition

Rank Sector Weight
1 Technology 22.3%
2 Healthcare 15.98%
3 Financials 14.49%
4 Consumer Discretionary 11.52%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLD
601
DELISTED
TopBuild
BLD
$13.6M 0.03%
+66,354
New +$13.9M
DAVA icon
602
Endava
DAVA
$154M
$13.6M 0.03%
100,000
+64,373
+181% +$8.31M
AEAC
603
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
$13.6M 0.03%
1,400,000
VTRS icon
604
Viatris
VTRS
$19B
$13.6M 0.03%
1,000,640
-12,910
-1% -$183K
LVS icon
605
Las Vegas Sands
LVS
$29.9B
$13.5M 0.03%
369,000
+19,500
+6% +$836K
NI icon
606
NiSource
NI
$20.8B
$13.3M 0.03%
550,362
+124,000
+29% +$3.09M
TASK icon
607
TaskUs
TASK
$716M
$13.3M 0.03%
200,000
-160,000
-44% -$7.59M
PTC icon
608
PTC
PTC
$16B
$13.3M 0.03%
110,700
-40,600
-27% -$5.41M
RPID icon
609
Rapid Micro Biosystems
RPID
$104M
$13.2M 0.03%
+716,666
New +$14.8M
OXUSU
610
DELISTED
Oxus Acquisition Corp. Unit
OXUSU
$13.2M 0.03%
+1,300,000
New +$13.1M
AAL icon
611
American Airlines Group
AAL
$10.6B
$13.2M 0.03%
642,550
-10,000
-2% -$203K
BF.B icon
612
Brown-Forman Class B
BF.B
$13B
$13.1M 0.03%
196,032
-2,800
-1% -$198K
AGCB
613
DELISTED
Altimeter Growth Corp 2
AGCB
$13.1M 0.03%
1,325,000
WRK
614
DELISTED
WestRock Company
WRK
$13.1M 0.03%
262,889
-4,100
-2% -$207K
NKGN
615
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$13.1M 0.03%
+1,350,000
New +$13.2M
FAST icon
616
Fastenal
FAST
$58.3B
$13.1M 0.03%
+505,958
New +$13.7M
IRM icon
617
Iron Mountain
IRM
$36.3B
$13.1M 0.03%
300,352
-4,500
-1% -$203K
EIX icon
618
Edison International
EIX
$25.9B
$13M 0.03%
235,004
-1,023,098
-81% -$58.7M
PHM icon
619
Pultegroup
PHM
$24.7B
$13M 0.03%
283,700
-4,000
-1% -$208K
JKHY icon
620
Jack Henry & Associates
JKHY
$11.2B
$13M 0.03%
79,286
-3,384
-4% -$582K
LNTH icon
621
Lantheus
LNTH
$6.6B
$12.8M 0.03%
500,000
LYV icon
622
Live Nation Entertainment
LYV
$42.3B
$12.8M 0.03%
140,175
-17,000
-11% -$1.43M
PUMP icon
623
ProPetro Holding
PUMP
$1.34B
$12.7M 0.03%
1,470,380
-650,000
-31% -$5.08M
CHRW icon
624
C.H. Robinson
CHRW
$17.1B
$12.7M 0.03%
145,900
-2,000
-1% -$181K
FMC icon
625
FMC
FMC
$1.32B
$12.7M 0.03%
138,600
-2,000
-1% -$197K

Similar funds

Adage Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
  • Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
  • Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
  • Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
  • Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
  • Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
  • Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.

Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.